Genetic Variation Associated with Alcoholic Liver Disease
By LabMedica International staff writers Posted on 05 Jan 2011 |
Genotyping has revealed that gene variation is strongly linked with cirrhosis of the liver and elevated transaminase levels in alcoholic Caucasians.
Blood tests for liver enzymes and genotyping of patients' DNA pinpoint the risk and susceptibility to progress towards alcoholic liver disease in those who drink excessive amounts of alcohol, which may be fatal.
Scientists from the University of Bern (Bern, Switzerland) and the Christian-Albrechts-University (Kiel, Germany) determined the genotype and allele frequencies of the adiponutrin or patatin-like phospholipase (PNPLA3) gene. Adiponutrin a transmembrane protein specifically expressed in adipose tissue. Participants in the study included 1,043 alcoholics with or without alcoholic liver injury and in 376 at-risk drinkers from a population-based cohort.
Cirrhosis and steatosis (fatty liver) were determined by liver biopsy and standard diagnostic testing. The liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in the serum of the participants were established using routine clinical chemistry testing. Participants were categorized as alcoholic liver cirrhosis (ALC); alcoholics with liver steatosis on ultrasound and elevation of ALT as alcoholic liver damage (ALD); alcoholic liver steatosis and normal liver enzyme levels as alcoholic fatty liver (AFL); and alcoholics with normal appearance of the liver on ultrasound and normal liver enzyme levels as alcoholic controls.
The results of the study showed that single nucleotide polymorphism (SNP) rs738409 was strongly over-represented in patients with ALC and ALD compared to alcoholics without liver damage. Additionally, the frequency of allele PNPLA3 rs738409 in AFL participants was lower than in alcoholics without steatosis and normal liver enzymes. The gene was associated with cirrhosis of the liver and elevated transaminase levels in alcoholic Caucasians.
Jochen Hampe, MD, the lead author, concluded that carriers with the genetic variation, PNPLA3 rs738409, represent a subpopulation of high-risk individuals susceptible to progression from clinically silent alcoholic liver disease to obvious cirrhosis. The study was published online December 7, 2010, in Hepatology.
Related Links:
University of Bern
Christian-Albrechts-University
Blood tests for liver enzymes and genotyping of patients' DNA pinpoint the risk and susceptibility to progress towards alcoholic liver disease in those who drink excessive amounts of alcohol, which may be fatal.
Scientists from the University of Bern (Bern, Switzerland) and the Christian-Albrechts-University (Kiel, Germany) determined the genotype and allele frequencies of the adiponutrin or patatin-like phospholipase (PNPLA3) gene. Adiponutrin a transmembrane protein specifically expressed in adipose tissue. Participants in the study included 1,043 alcoholics with or without alcoholic liver injury and in 376 at-risk drinkers from a population-based cohort.
Cirrhosis and steatosis (fatty liver) were determined by liver biopsy and standard diagnostic testing. The liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in the serum of the participants were established using routine clinical chemistry testing. Participants were categorized as alcoholic liver cirrhosis (ALC); alcoholics with liver steatosis on ultrasound and elevation of ALT as alcoholic liver damage (ALD); alcoholic liver steatosis and normal liver enzyme levels as alcoholic fatty liver (AFL); and alcoholics with normal appearance of the liver on ultrasound and normal liver enzyme levels as alcoholic controls.
The results of the study showed that single nucleotide polymorphism (SNP) rs738409 was strongly over-represented in patients with ALC and ALD compared to alcoholics without liver damage. Additionally, the frequency of allele PNPLA3 rs738409 in AFL participants was lower than in alcoholics without steatosis and normal liver enzymes. The gene was associated with cirrhosis of the liver and elevated transaminase levels in alcoholic Caucasians.
Jochen Hampe, MD, the lead author, concluded that carriers with the genetic variation, PNPLA3 rs738409, represent a subpopulation of high-risk individuals susceptible to progression from clinically silent alcoholic liver disease to obvious cirrhosis. The study was published online December 7, 2010, in Hepatology.
Related Links:
University of Bern
Christian-Albrechts-University
Latest Molecular Diagnostics News
- World’s First One-Minute Hepatitis C Antibody Test Facilitates Quick Triage
- Game-Changing Blood Test for Stroke Detection Could Bring Life-Saving Care to Patients
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis